Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
94 GBX | -1.67% | +4.44% | +8.92% |
May. 07 | AstraZeneca target raised; Antofagasta lowered | AN |
Apr. 17 | De La Rue says yearly profit to be in line with expectations | AN |
Sales 2024 * | 319M 405M | Sales 2025 * | 354M 450M | Capitalization | 184M 234M |
---|---|---|---|---|---|
Net income 2024 * | -3M -3.81M | Net income 2025 * | 11M 13.97M | EV / Sales 2024 * | 0.89 x |
Net Debt 2024 * | 99.23M 126M | Net Debt 2025 * | 92.42M 117M | EV / Sales 2025 * | 0.78 x |
P/E ratio 2024 * |
-46.6
x | P/E ratio 2025 * |
16.2
x | Employees | 1,841 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.73% |
Latest transcript on De La Rue plc
1 day | -1.67% | ||
1 week | +4.44% | ||
1 month | +17.21% | ||
3 months | +6.46% | ||
6 months | +61.51% | ||
Current year | +8.92% |
Managers | Title | Age | Since |
---|---|---|---|
Clive Vacher
CEO | Chief Executive Officer | - | 19-10-06 |
Dean Moore
DFI | Director of Finance/CFO | 66 | 23-06-25 |
Ruth Euling
BRD | Director/Board Member | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Dean Moore
DFI | Director of Finance/CFO | 66 | 23-06-25 |
Nicholas Bray
BRD | Director/Board Member | 59 | 16-07-20 |
Brian Small
BRD | Director/Board Member | 67 | 23-09-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 94 | -1.67% | 101,814 |
24-05-16 | 95.6 | +0.21% | 161,147 |
24-05-15 | 95.4 | +3.02% | 192,285 |
24-05-14 | 92.6 | +4.04% | 86,050 |
24-05-13 | 89 | -1.11% | 579,701 |
Delayed Quote London S.E., May 17, 2024 at 11:35 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+8.92% | 234M | |
-1.40% | 7.86B | |
+14.52% | 7.37B | |
+10.33% | 2.25B | |
-36.26% | 1.21B | |
+180.00% | 1.21B | |
+7.37% | 1.01B | |
-12.10% | 931M | |
-5.75% | 537M | |
-19.74% | 533M |
- Stock Market
- Equities
- DLAR Stock